For Investors

We’re proud to bring early stage entrepreneurs and investors together through our programs, matching people who can form long-term, mutually beneficial relationships. Our main program for matchmaking is the annual Rosenman Innovator cycle; in addition, we make connections all year long through our dinners, speaker series and direct introductions. Contact us to learn about ways to engage with our community of entrepreneurs.

Contact Us

Companies in our Ecosystem

View all

Aluna

Aluna’s digital spirometer has hospital-grade accuracy and has been FDA-cleared for use by children (and adults).

Learn more

Bisu

Burn fat, train better and protect your health with Bisu Body Coach, a smart urine analyzer that gives you personalized diet advice.

Learn more

Avisi

Developing a nanotechnology-enabled defense against blindness from glaucoma

Learn more

Our Impact

The UCSF Rosenman Institute has been supporting transformative health technology companies from concept to commercialization since 2014.
300000
Patients Impacted
690000000
Million Dollars Raised
18
FDA Approvals

News

We want to keep you abreast of the newest advancements in the health tech sector and share when our companies make headlines.
View all
Jan 19, 2021
ConsejoSano Named to Fierce 15 in Healthcare
ConsejoSano has developed technologies designed to reduce disparities in healthcare provision by connecting users with people from a shared cultural background who can help them navigate their way through the system.
Jan 19, 2021
Relign Acquired by Zimmer Biomet
RELIGN’s Tricera is a revolutionary, advanced system that combines ablation/coagulation, tissue resection, bone cutting, and fluid management into one unique system
Jan 19, 2021
Koya Medical Closes $11M Financing to Accelerate Treatment for Lymphedema
Koya Medical recently received FDA-clearance for the Dayspring™ product platform, a prescription only active wearable compression system for the treatment of lymphedema.